Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)

• Status: Completed
• Trial end date: 2017-07-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daewoong Pharmaceutical Co. LTD.

Criteria

Inclusion Criteria:

• Male and female of at least 19 years old

• Patient with functional dyspepsia met the ROME III criteria

Exclusion Criteria:

• Patients with previous gastrointestinal surgery

• Patients with history of gastrointestinal bleeding, mechanical obstruction, perforation

• Patients with history of gastrointestinal cancer